Announcements Trials
Browse Landscape

Status

Recruiting 28Unknown 22Completed 16Not yet recruiting 9Active not recruiting 9Terminated 5Withdrawn 3Enrolling by invitation 3Suspended 2

Sponsor Class

OTHER 2

Study Type

Interventional 8Observational 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 16Neoplasms 11Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 4Lung Neoplasms 4Polycystic Ovary Syndrome 3Ovarian Neoplasms 3Glioblastoma 3Diabetes Mellitus 3Crohn Disease 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Non-alcoholic Fatty Liver Disease 2Multiple Sclerosis 2Irritable Bowel Syndrome 2Glioma 2Endometrial Neoplasms 2Dyslipidemias 2Colonic Neoplasms 2Colitis, Ulcerative 2Celiac Disease 2Carcinoma, Renal Cell 2Arthritis, Rheumatoid 2Vulvar Diseases 1Vitamin D Deficiency 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Observational × Triple Negative Breast Neoplasms × Clear all
NCT04803084 2024-11-20

Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment

Vanderbilt-Ingram Cancer Center

Suspended
10 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04250818 2021-05-19

Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile

Texas Tech University Health Sciences Center, El Paso

Suspended
20 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡